HomeBusinessHealthcareDexcom (DXCM) Earnings Call & Stock Price
Dexcom (DXCM) Earnings Call & Stock Price

Dexcom (DXCM) is the largest provider of continuous glucose monitoring system and software. They reported earnings April 28 and missed on EPS but beat on revenue. George Tsilis discusses the miss on EPS and explains Dexcom is aggressively spending on technology and capital expenditures. He compares it to its peers Abbott Labs and Medtronic. Morgan Stanley keeps an outperform rating on Dexcom but lowered its price target to $492 from $514, says George. George explains his bullish short put trade. Tune in for the full discussion.

Trading 360

29 Apr 2022

ON AIR
1:30 am
Next Gen Investing
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
ON AIR
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
education
9:30 am
Your First Trade
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
education
4:30 pm
Your First Trade
REPLAY
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
education
8:00 pm
Your First Trade
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US